FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2565404310> ?p ?o ?g. }

• W2565404310 abstract "An important percentage of disease causing mutations affects pre-mRNA splicing. The mechanism of pre-mRNA splicing is controlled by sequence elements within the exons and introns. These sequence elements recruit the spliceosome for directing the splicing process. Mutations disrupting the sequence elements commonly result in exon exclusion or cryptic exon inclusion named as pseudoexon. The result is typically a frame-shift in the pre-mRNA causing production of partially functional or a defective protein. A common way to correct splicing mutations is to use antisense oligonucleotides (AONs) that are short complementary sequences that bind to the pre-mRNA and re-direct the splicing.X-linked agammaglobulinemia (XLA) is a primary immunodeficiency disease that is caused by the mutations in the gene named Bruton's Tyrosine Kinase (BTK). BTK has a crucial role in B cell development and the absence of BTK introduces a developmental block at the stage where the transition between pro-B and pre-B cells takes place. A prominent percentage of splicing mutations affect pre-mRNA splicing in XLA [1]. Previously, we have published a proof-of-concept study and shown that AONs can correct a cryptic exon mutation and restore a functional BTK in a humanized transgenic mouse model both in vitro and in vivo [2]. AONs in the previous study were designed to sterically block an intronic mutation and prevent the recruitment of the splicing factors around the cryptic exon.We are here addressing a different scenario, where defective BTK is produced due to exon exclusion. This is typically due to mutations that weaken the splice sites or splicing enhancer sequences in their vicinity, and constitutes the most common type of splicing defect. Here we have designed bifunctional AONs that have a complementary binding site and a free tail region that is able to recruit splicing factors to the site in order to enhance exon inclusion. Initially, we constructed a library of BTK reporters with mutations known to cause XLA, and the bifunctional AONs were then tested in cultures of cells stably transfected with various BTK reporters for intronic mutations affecting the inclusion of BTK exons 16 and 17. These exons were selected owing to the rather small size of the corresponding introns simplifying the generation of relevant reporter cell lines. Screening of different tail sequences show that AONs designed to recruit TIA-1 or TDP-43 proteins can correct the splicing defects and give rise to wild-type BTK mRNA. Optimization of the antisense and tail parts of the AONs has also revealed the importance of chemical modifications (2’-O-methyl, phosphorothioate, and/or locked nuclei acid) for enhancing the efficacy of the AONs. We have also studied the influence of combining bifunctional AONs and found that this can profoundly enhance exon inclusion. Thus, depending on the exact type of mutation single or combinatorial approaches provide different outcomes. To the best of our knowledge, this is the first time that exon inclusion has been achieved in a hematopoietic setting and experiments are currently underway to further optimize and explore the design of bifunctional AONs for potential in vivo use.1. Bestas, B., et al., Splice-correction strategies for treatment of x-linked agammaglobulinemia. Current Allergy and Asthma Reports, 2015. 15(3): p. 510.2. Bestas, B., et al., Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model. The Journal of Clinical Investigation, 2014. 124(9): p. 4067-81." @default.
• W2565404310 created "2017-01-06" @default.
• W2565404310 creator A5037433972 @default.
• W2565404310 creator A5080177447 @default.
• W2565404310 creator A5084599077 @default.
• W2565404310 creator A5091658806 @default.
• W2565404310 date "2016-05-01" @default.
• W2565404310 modified "2023-10-01" @default.
• W2565404310 title "581. Correcting Exon Skipping Splicing Defects in BTK RNA by Using Bifunctional Oligonucleotides" @default.
• W2565404310 doi "https://doi.org/10.1016/s1525-0016(16)33389-5" @default.
• W2565404310 hasPublicationYear "2016" @default.
• W2565404310 type Work @default.
• W2565404310 sameAs 2565404310 @default.
• W2565404310 citedByCount "0" @default.
• W2565404310 crossrefType "journal-article" @default.
• W2565404310 hasAuthorship W2565404310A5037433972 @default.
• W2565404310 hasAuthorship W2565404310A5080177447 @default.
• W2565404310 hasAuthorship W2565404310A5084599077 @default.
• W2565404310 hasAuthorship W2565404310A5091658806 @default.
• W2565404310 hasBestOaLocation W25654043101 @default.
• W2565404310 hasConcept C104317684 @default.
• W2565404310 hasConcept C153911025 @default.
• W2565404310 hasConcept C166342232 @default.
• W2565404310 hasConcept C194583182 @default.
• W2565404310 hasConcept C2778776201 @default.
• W2565404310 hasConcept C36823959 @default.
• W2565404310 hasConcept C40000846 @default.
• W2565404310 hasConcept C42362537 @default.
• W2565404310 hasConcept C42576000 @default.
• W2565404310 hasConcept C501734568 @default.
• W2565404310 hasConcept C54355233 @default.
• W2565404310 hasConcept C54458228 @default.
• W2565404310 hasConcept C62478195 @default.
• W2565404310 hasConcept C67705224 @default.
• W2565404310 hasConcept C86803240 @default.
• W2565404310 hasConcept C90059517 @default.
• W2565404310 hasConcept C94671646 @default.
• W2565404310 hasConceptScore W2565404310C104317684 @default.
• W2565404310 hasConceptScore W2565404310C153911025 @default.
• W2565404310 hasConceptScore W2565404310C166342232 @default.
• W2565404310 hasConceptScore W2565404310C194583182 @default.
• W2565404310 hasConceptScore W2565404310C2778776201 @default.
• W2565404310 hasConceptScore W2565404310C36823959 @default.
• W2565404310 hasConceptScore W2565404310C40000846 @default.
• W2565404310 hasConceptScore W2565404310C42362537 @default.
• W2565404310 hasConceptScore W2565404310C42576000 @default.
• W2565404310 hasConceptScore W2565404310C501734568 @default.
• W2565404310 hasConceptScore W2565404310C54355233 @default.
• W2565404310 hasConceptScore W2565404310C54458228 @default.
• W2565404310 hasConceptScore W2565404310C62478195 @default.
• W2565404310 hasConceptScore W2565404310C67705224 @default.
• W2565404310 hasConceptScore W2565404310C86803240 @default.
• W2565404310 hasConceptScore W2565404310C90059517 @default.
• W2565404310 hasConceptScore W2565404310C94671646 @default.
• W2565404310 hasLocation W25654043101 @default.
• W2565404310 hasOpenAccess W2565404310 @default.
• W2565404310 hasPrimaryLocation W25654043101 @default.
• W2565404310 hasRelatedWork W1974762136 @default.
• W2565404310 hasRelatedWork W1998434274 @default.
• W2565404310 hasRelatedWork W2014840108 @default.
• W2565404310 hasRelatedWork W2033959597 @default.
• W2565404310 hasRelatedWork W2051233811 @default.
• W2565404310 hasRelatedWork W2059027168 @default.
• W2565404310 hasRelatedWork W2075056041 @default.
• W2565404310 hasRelatedWork W2084068585 @default.
• W2565404310 hasRelatedWork W2105010877 @default.
• W2565404310 hasRelatedWork W2108405889 @default.
• W2565404310 hasRelatedWork W2119580172 @default.
• W2565404310 hasRelatedWork W2160894133 @default.
• W2565404310 hasRelatedWork W2166863344 @default.
• W2565404310 hasRelatedWork W2174530025 @default.
• W2565404310 hasRelatedWork W2520062272 @default.
• W2565404310 hasRelatedWork W2592966672 @default.
• W2565404310 hasRelatedWork W2796118888 @default.
• W2565404310 hasRelatedWork W2950896242 @default.
• W2565404310 hasRelatedWork W2979789983 @default.
• W2565404310 hasRelatedWork W298306700 @default.
• W2565404310 isParatext "false" @default.
• W2565404310 isRetracted "false" @default.
• W2565404310 magId "2565404310" @default.
• W2565404310 workType "article" @default.